Immuron Ltd has released a press release.
Immuron Receives European Patent on Drug to Treat Diarrhea
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Immuron
- US DoD Travelan Clinical Update
- US DoD Naval Medical Research Center Clinical Update
- IMM124E Demonstrates Antiviral T-Cell Immunity
- Reinstatement to Official Quotation
- Immuron planned Acquisition of R&D Vaccine Company
Later from Immuron
- Response to ASX Query
- Half Yearly Report and Accounts
- Immuron Q3 Global Sales up 216% YoY
- Appointment of Mr Steven Lydeamore as Chef Executive Officer
- US DoD Uniformed Services University Clinical Update
Follow Immuron into a list and get an email when it puts out news.
Follow Immuron